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ABSTRACT
Background: In the elderly, there is a decrease in lung vital capacity to 68%. The prevalence of hypertension 
is at the age above 65 years with 13% of the population. The Incidence of lung function decline in chronic heart 
failure and hypertension was found mainly in the elderly.
Aims: The aim of the study was to know the differences in lung function in elderly patients with and without 
hypertension.
Methods: The Study was cross-sectional, a study in November 2012 until January 2013 of the elderly population 
over 60 years of research with a sample of 58 people (29 people and 29 groups of hypertensive people without 
hypertension). Inclusion criteria for the study subjects were elderly patients over 60 years of signing the informed 
consent, can perform spirometry maneuvers correctly. Data were analyzed by T-test to examine some differences 
in the mean or median, between the two groups. 
Results: In this research, there were no signifi cant difference in lung function as measured by FVC and FEV1 
in the elderly with hypertension and without hypertension (p = 0.984, 95% CI-0, 13-0,139 for FVC and p = 0.83, 
95 IK-0, 14-0,116% for FEV1). 
Conclusion: There is no signifi cant difference in lung function in the elderly with and without hypertension.
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INTRODUCTION
Aging process occurs in elderly, structurally and 
functionally, called as degeneration.1 The effect of a 
cellular aging on a lung function is not fully understood.2 
Lung function was measured by spirometry to determine 
the value of FVC (liters) and FEV1 (liters). A Study reported 
that FVC and FEV1 decreased in the elderly who also 
had hypertension and cardiovascular disease.3 The 
prevalence of hypertension in elderly population aged 
60-65 years ranged from 60% to 80%. This suggests 
that the etiology and hemodynamic mechanism of 
hypertension in the elderly population may  relate to 
different molecular mechanisms such as telomere.4 
Prevalence of hypertension in elderly group aged 65 years 
is 13%. It is predicted that the percentage will increase to 
20% by the year 2050.5
The Cardiovascular Health Study shows that low 
FEV1 associated with a high incidence of stroke in 
men with hypertension.6 The incidence of lung function 
declines in chronic heart failure, coronary artery disease 
and hypertension. It is interesting to determine that 
cardiovascular disease, hypertension and left ventricular 
hypertrophy clinically associated with worsening lung 
function.7 Framingham study demonstrated that the 
decline in lung function, detected by low forced vital 
capacity (FVC) and forced expiratory volume in the fi rst 
second (FEV1), associated with coronary heart disease 
and hypertension.8 Relationship between hypertension 
and pulmonary function is often observed in the last 
decade, especially in the elderly where arterial elasticity 
contributes to this mechanism.9
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This study aims to determine the difference 
of lung function in elderly patients with and without 
hypertension.
LITERATURE REVIEW
Aging Theory
Terminology defi nes that elderly is individual 
ages over 60 years and characterized by a variety 
of physiological changes and mental function.10 The 
aging process triggers some changes in the respiratory 
system that results in a decrease in lung function.11 In 
the elderly population cellular changes occur. These 
mechanisms include the decline in lung function.2 
Forced expiratory volume in the fi rst second (FEV1) 
deteriorated by aging is greater than the decline of 
forced vital capacity (FVC) and the ratio of FEV1 and 
FVC also decreases with age.7 Lung Function and 
Hypertension Spirometry test are the main objective 
examination to determine disorder in respiratory 
system,12 including measurement of FVC, FEV1, and 
forced expiratory.13 In the elderly there is an increase 
of systolic blood pressure resulting in increased 
after-load cardiac volume ensuring a left ventricular 
hypertrophy (LVH). The decrease of diastolic blood 
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pressure causes a decreased coronary perfusion, 
allowing ischemic heart disease. LVH and ischemic 
heart disease will then cause systolic and diastolic 
heart failure.5 The background of relationship between 
lung function decline and hypertension is unknown. It 
is left ventricular failure that possibly causes vascular 
and interstitial edema, which lowers compliance of 
lungs, and produces a decrease in the value of FVC. 
Another explanation of the mechanism is the effects 
of the aging process it self.14
Inclusion criteria
Patients with age > 60 Years 
old signing the informed 
consent can performs 
spirometry maneuvers 
correctly.
Patients with age > 60 years old with ADL independently who visits 
regularly once in a month in the group of Paguyuban Adiyuswo geriatric, 
dr. Sardjito General Hospital, Yogyakarta
Affordable population
Patients with age > 60 years old
Exclusion criteria
Asthma
COPD
Chronic heart failure
Edema
Diabetes Mellitus
Stroke
Musculoskeletal disorder
History of thoracic surgery
History of work exposure to 
chemical
Blood pressure measurement
By sfi gmomanometer
Without hypertensionhypertension
Checkup electro radiography
Measurement: Spirometry Ventrilometer VMI Clement Clarke, 
cat No. 3108001 Reg. Des no. 106400. Patient`s applied for made in the UK 
Sweden battery 9 volt
Checkup electro radiography
FVC and FEV1
Statistical Analysis
METHODS
Sample Population
The study was conducted cross-sectionally in 
local setting of “Geriatric Association” (Paguyuban 
Geriatri) and Pulmonoly Department, Dr. Sardjito 
Hospital, Yogyakarta, from November 2012 to January 
2013. The population was elderly patients aged over 60 
years who were capable and independent. Individuals 
visits Paguyuban Adiyuswo Geriatry Dr. Sardjito 
Fig 1. Research design
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Hospital, Yogyakarta regularly in a monthly basis. 
Inclusion criteria included signing the informed consent 
and having capability in doing spirometry maneuvers 
correctly. Subjects with asthma, chronic pulmonary 
obstructive disease (COPD), chronic heart failure, 
edema, diabetes mellitus, stroke, musculoskeletal 
disorders, the history of thoracic surgery, and regular 
working with chemical exposure were excluded. 
After undergoing interview and  physical examination 
study subjects were grouped into hypertensive (blood 
pressure ≥ 140/90) and non hypertensive individuals 
(blood pressure < 140/90 mmHg). Afterward, spirometry 
with FVC and FEV1 measurements were carried out.
 
Statistic Analysis
Student t-test was used to analyze  differences  of  mean 
or median  between  the  two groups. Signifi cance was 
accepted  with p < 0.05. 
RESULT AND DISCUSSION 
The mean FVC obtained in hypertensive and 
non- hypertensive group is 0.58 ± 0.25 and 0.59 ± 0.26, 
respectively (p = 0.984, 95% CI -0.13 - 0.139). The mean 
FEV1 in groups with and without hypertension wass 0.549 
± 0.24 vs. 0.53 ± 0.24 (p = 0.83, 95% CI - 0.14 - 0.116). 
Average value of predicted FVC is 22.92 ± 10.35 vs. 23.34 
± 10.66 (p = 0.88, 95% CI -5,11-5,95), while average value 
of predicted FEV1 is 38.60 ± 16.47 vs. 34.95 ± 14.89 
(p = 0.379, 95% CI -11, 9-4, 59). This shows that there 
is no signifi cant difference to the FVC, FEV1, FVC and 
predicted FEV1 in the hypertensive and non hypertensive 
group. This is in contrast to the reports ofprevious studies 
despite different age populations. Karunanayake et 
al. (2003) showed that patients with hypertension and 
cardiovascular disease have a lower lung function. 
The different result may be caused by different study 
populations of our present work. Ours included only elderly 
individuals aged more than 60 years, while previous study 
had subjects aged 18-79 years, suporting indication that 
hypertension in elderly patients is distinct from adult 
patients.4 Moreover, ECG results in the two group of the 
present study showed no signifi cant difference of lung 
function when determined by the presence of ischemia 
and LVH. This is in contrast to the report of Enright (1995) 
showing that in chronic heart failure, hypertension with 
increased left atrial pressure and left ventricular ischemic 
lower compliance increasedpulmonary arterial pressure. 
This resulted in a decline in FVC and FEV1. There is a 
relationship worsening of lung function in patients with 
chronic heart and hypertension.7
CONCLUSION
No signifi cant differences in lung function were 
found in elderly patient with and without hypertension. 
However, this study open up an opportunity for 
further exploration with better study design since the 
knowledge of lung function in elderly in its relationship to 
hypertension may provide improved strategy to reduce 
morbidity, mortality and enhance quality of life.
Table 1. Paired Samples T-test of hypertension and without hypertension group
Parameter
Mean of group with 
hypertension ±SB 
(n = 29)
Mean of group without 
hypertension ± SB 
(n = 29)
P value 95% IK
Age (years) 69,55 ± 6,99 67,50 ± 6,67 P = 0, 246 -5.69-1,49
Gender
Male (n = 16)
Female (n = 46)
12 (41, 38%)
17 (58, 62%)
4 (13, 79%)
25 (86, 21%)
P = 0,0038 0.062-0,822
Weight (kg) 55,20 ± 13,31 57,17±13,31 P = 0,535 -4.34-8.27
Height (cm) 155 ± 5,91 154 ± 6,70 P = 0,620 -4.15-2.5
BMI (kg/m2) 24,01 ± 5,45 22,95 ± 4,59 P = 0,473 -3,938-1.985
Waist (cm)
Male
Female
84,75 ± 8,22
83,79 ± 11,64
87,16 ± 16,79
87,08 ± 12,64
P = 0,720
P = 0,415
-10.948-15.448
-4.767-11.346
Smoking history (%)
Yes (n = 4)
No(n = 54)
2 (6, 89%)
27 (93, 11%)
2 (6, 89%)
27 (93, 11%)
P = 1 0,13-7,62
EKG (%)
Ischemic (n = 40)
Without ischemic (n=18)
LVH (n = 12)
Without LVH (n = 46)
23 (79, 31%)
6 (20, 69%)
4 (13, 79%)
25 (86, 21%)
17 (68, 75%)
12 (31, 25%)
8(27, 56%)
21(72, 44%)
P = 0,155
P = 0,331
0,845-8,66
0,628-9,03
FVC (L) 0,58 ± 0,25 0,59 ± 0,26 P = 0,984 -0,13-0,139
FEV1 (L) 0,54 ± 0,24 0,53 ± 0,24 P = 0,83 -0,4-0,116
FVC prediction (%) 22,92 ± 10,36 23,34 ± 10,66 P = 0,88 -5,11-5,95
FEV1 prediction (%) 38,60 ± 16,47 34,95 ± 14,89 P = 0,379 -11,9-4,59
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